- Home
- OBT vs ALDX Comparison
OBT vs ALDX Comparison
Compare OBT & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- ALDX
- Stock Information
- Founded
- OBT 1892
- ALDX 2004
- Country
- OBT United States
- ALDX United States
- Employees
- OBT N/A
- ALDX N/A
- Industry
- OBT Major Banks
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- ALDX Health Care
- Exchange
- OBT Nasdaq
- ALDX Nasdaq
- Market Cap
- OBT 315.3M
- ALDX 304.9M
- IPO Year
- OBT N/A
- ALDX 2014
- Fundamental
- Price
- OBT $26.07
- ALDX $5.40
- Analyst Decision
- OBT Buy
- ALDX Strong Buy
- Analyst Count
- OBT 1
- ALDX 2
- Target Price
- OBT $35.50
- ALDX $10.00
- AVG Volume (30 Days)
- OBT 29.5K
- ALDX 394.0K
- Earning Date
- OBT 02-11-2025
- ALDX 03-06-2025
- Dividend Yield
- OBT 2.30%
- ALDX N/A
- EPS Growth
- OBT N/A
- ALDX N/A
- EPS
- OBT 2.56
- ALDX N/A
- Revenue
- OBT $98,024,000.00
- ALDX N/A
- Revenue This Year
- OBT N/A
- ALDX N/A
- Revenue Next Year
- OBT $4.83
- ALDX N/A
- P/E Ratio
- OBT $10.18
- ALDX N/A
- Revenue Growth
- OBT 4.93
- ALDX N/A
- 52 Week Low
- OBT $20.50
- ALDX $2.71
- 52 Week High
- OBT $33.06
- ALDX $6.55
- Technical
- Relative Strength Index (RSI)
- OBT 39.58
- ALDX 60.04
- Support Level
- OBT $25.92
- ALDX $4.95
- Resistance Level
- OBT $26.79
- ALDX $5.10
- Average True Range (ATR)
- OBT 0.97
- ALDX 0.24
- MACD
- OBT 0.09
- ALDX 0.04
- Stochastic Oscillator
- OBT 33.76
- ALDX 85.06
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.